Evan Gibson
evan.gibson.wg12@
wharton.upenn.edu Yale University, New Haven, CT B.A., Economics, 2004 University of Pennsylvania, School of Engineer- ing and Applied Sciences, Philadelphia, PA M.B. Candidate, Biotechnology, 2012
Kyle G. Gilbride
kyle.gilbride.wg12@
wharton.upenn.edu Dartmouth College, Hanover, NH A.B., Magna Cum Laude, History, 2005
R. Scott Glass
ronald.glass.wg12@
wharton.upenn.edu Wake Forest University, Winston-Salem, NC B.S., Cum Laude, Analytical Finance, 2005
A strategic marketing or business development opportunity at a biophar- maceutical or diagnostic company.
Abbott Laboratories, Abbott Park, IL MBA Intern, Immunology, Summer 2011 Collaborated with Senior Managers of a specialized sales force to develop strategies and tactics for hospital accounts. Assessed recent develop- ments in the Section 340B Drug Pricing Program and developed recommenda- tions for maintaining the long-term success of the immunology franchise. Worked closely with sales representa- tives and consultants to create an account segmentation tool to standardize key tactics for different types of hospitals.
JMP Securities, San Francisco, CA Senior Associate, 2007-2010 Analyst, 2004-2007 Helped build the Life Sciences Invest- ment Banking Group while completing 35 financings totaling $2B in gross proceeds and 3 M&A transactions representing over $260M in value. Managed cross-functional teams that included C-level management, lawyers, accountants, and JMP personnel to execute financing transactions. Spear- headed clinical, regulatory, and finan- cial due diligence for numerous clients and prospective clients. Developed strategic and financing recommenda- tions and presented to client manage- ment teams and directors.
An opportunity to operate and invest in innovative healthcare companies.
Medtronic, Minneapolis, MN Summer Leadership Development Marketing Associate, Summer 2011 Evaluated next-generation cardiac device data analytics portfolio to improve customers’ clinical and economic outcomes. Identified key product attributes and developmental considerations through customer interviews and competitive research. Assessed organizational capabilities to successfully launch and monetize suite of data solutions. Led cross-functional team in creating new data reporting tool for injectable cardiac monitoring device.
Ferrer Freeman & Company, Greenwich, CT Associate, 2008-2010 Analyzed private equity investment opportunities for a $900M healthcare- focused fund. Provided strategic guidance to 3 portfolio companies as a Board observer. Partnered with senior management to execute portfolio companies’ strategic plans, improve operations, and identify acquisition targets. Designed pricing model for pharmaceutical marketing provider, improving profit margins and business development initiatives.
Thomas Weisel Partners, New York, NY Analyst, 2005-2008 Provided corporate finance and strategic advisory services to growth- stage healthcare companies. Managed marketing of Obagi Medical Products’ $145M common stock offering. Evaluated 15 acquisition targets for Noven Pharmaceuticals, resulting in $125M acquisition of JDS Pharmaceuti- cals. Created fairness opinion for FoxHollow Technologies’ $780M merger with ev3.
An opportunity to build successful businesses through healthcare focused private equity investing.
Solstas Lab Partners, Greensboro, NC Intern, Welsh Carson Portfolio Company, Summer 2011 Managed due diligence and developed integration plans for four add-on acquisitions in the clinical lab sector. Facilitated lender communication and diligence process for debt refinancing to support acquisitions.
Tailwind Capital Partners, New York, NY Associate, 2008-2010 Evaluated healthcare and business services investments for the firm’s $775M inaugural fund. Led top-down industry analysis, formed investment thesis, fostered new relationships with intermediaries and executives to identify new investment opportunities. Worked closely with portfolio compa- nies to manage capital requirements and execute their strategic growth plans.
American Capital, Washington, DC Associate, 2007-2008 Reviewed buyout investment opportu- nities across the firm’s core focus sectors including outsourced business services, logistics and healthcare services. Developed investment thesis and managed diligence processes to facilitate transaction closings.
Wachovia Securities, Charlotte, NC Investment Banking Analyst, 2005-2007 Worked across the healthcare, technol- ogy and business services industries to structure equity and mezzanine private placements for growth-stage companies. Developed core analytical and financial skills and presented analyses to clients’ executive teams.
12
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40